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The present work aims to synthesize and screen the antifungal and antibacterial activities of a series of new 1-hepta-
O-benzoyl-β-D-maltosyl-4-benzothiazolyl semicarbazides by the interaction of hepta-O-benzoyl-β-D-maltosyl 
isocyanate and substituted 2-hydrazino benzothiazoles in acetone medium. The identities of these newly synthesised 
1-hepta-O-benzoyl-β-D-maltosyl-4-benzothiazolyl semicarbazides have been established on the basis of usual 
chemical transformations and IR, H
1 
NMR and Mass spectral studies. These synthesized products were evaluated for 
their antimicrobial activity against some selected organisms. Some of the products displayed promising activity.   
Keywords: Maltosyl isocyanate, hydrazino benzothiazoles, maltosyl benzothiazolyl semicarbazides, antimicrobial 
activity.  
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INTRODUCTION 
Isocyanates of sugars are one of the versatile reagents in the field of synthetic carbohydrate chemistry. 
Many of these derivatives have been found to possess wide applications in industry as carbohydrate base 
detergent and in medicine as anticancer and antifungal agents. The maltosylated derivatives show great 





 and antitumour agent
3
. Heterocycles bearing thiazole, sulphur and nitrogen moieties constitute the 
core structure of a number of pharmacologically and biologically active interesting compounds. A 









and anticonvulsant8 activities. These findings encouraged us to explore the synthesis and to examine 
antibacterial and antifungal properties of new synthesized semicarbazides. 
 
EXPERIMENTAL 
The reagent grade chemicals were obtained from commercial sources and purified by either distillation or 
recrystallization before use. Melting points of all synthesized compounds were determined using open 
capillary tube on Mac digital melting point apparatus and were uncorrected. IR spectra were recorded in 




NMR spectra in CDCl3 on 
Bruker DRX-300 of NMR spectrometer 300 MHz. The Mass spectra were recorded on Waters UPLC-
TQD Mass Spectrometer. Optical rotations were measured on Equip-Tronics EQ 800 Digital Polarimeter 
in CHCl3.  Purity of synthesized compounds has been checked by thin layer chromatography. It was 
performed on E. Merck precoated silica gel plates. 
 
General Procedures 
Synthesis of hepta-O-benzoyl-β-D-maltosyl isocyanate (1)   
To the suspension of hepta-O-benzoyl-α-D-maltosyl bromide (0.039 M, 15 g) in sodium dried xylene (60 
ml) was added lead cyanate (0.039 M, 4.5 g). The mixture was refluxed gently for 3 h. The xylene filtrate 
was then treated with petroleum ether (60-80oC) to afford a solid. It was purified by dissolving it in 
minimum quantity of chloroform and reprecipitating with petroleum ether (Scheme-1).   
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Synthesis of 2-hydrazino benzothiazoles (2a-g) 
Concentrated HCl (1 ml) was added drop wise to hydrazine hydrate (0.2 M, 1 ml 80%) at 5-10
o
C 
followed by ethyleneglycol (20 ml). To the above solution 2-amino benzothiazole (0.01 M, 1.85g) was 
added in portions. It was then refluxed for 3 h, cooled and poured onto crushed ice. The separated solid 
was filtered, dried and recrystalized from ethanol(Scheme-2).  
 
Synthesis of 1-hepta-O-benzoyl-β-D-maltosyl-4-benzothiazolyl semicarbazides  
A acetone solution of hepta-O-benzoyl-β-D-maltosyl isocyanate (0.025M, 2.5g in 20 ml) was mixed with 
acetone solution of 2-hydrazino benzothiazole (0.025M, 0.37g in 10 ml) and mixture after shaking for 
sometime was refluxed on water bath for 3.30 h. Acetone was distilled off to obtained sticky residue. This 
residue was triturated several times with petroleum ether to afford a light coloured solid (Scheme-3).   
 
 




Table-2: Antimicrobial activities of newly synthesized 1-hepta-O-benzoyl-β-D-maltosyl-4-benzothiazolyl 
semicarbazides (3a-g). 
 
**Including the well diameter of 6 mm. Zone of inhibition in mm (15 or less) resistant, (16-20 mm) moderate and (more than 20 mm) sensitive. 
 
RESULTS AND DISCUSSION 
All products were crystallized from ethanol before recording the physical data (Table-1). The purity of 
compounds was checked by TLC. The spectral analysis9-11 IR, 1H NMR and Mass spectra of the product 
were observed. Optical rotation of the product was also recorded. All the compounds have been screen for 
both antimicrobial and antifungal activity using cup plate agar diffusion method
12-13
 by measuring the 
inhibition zone in mm. Amikacin (100 µg/ml) was used as standard for antibacterial activity and 
Fluconazole (100 µg/ml) as standard for antifungal activity. Antibacterial studies of these compounds 




















1. 3a 2.7 (84.63) 119-121 4.35 (4.44) 2.56 (2.53) +70
o 
(0.50) 0.66 
2. 3b 2.6 (87.24) 124-126 4.19 (4.32) 2.69 (2.47) +95
o 
(0.53) 0.60 
3. 3c 2.8 (77.56) 131-133 4.15 (4.32) 2.77 (2.47) -108
o 
(0.51) 0.59 
4. 3d 2.5 (85.47) 126-128 4.17 (4.32) 2.58 (2.47) +122
o 
(0.51) 0.62 
5. 3e 2.4 (72.39) 135-137 4.25 (4.39) 2.08 (2.51) -89
o 
(0.52) 0.54 
6. 3f 2.7 (75.13) 129-130 4.30 (4.39) 2.91 (2.51) +104
o 
(0.50) 0.51 


















3a 21 24 17 24 19 21 22 
3b 19 20 19 23 18 23 24 
3c 17 18 - 12 13 19 23 
3d 20 17 21 20 21 21 21 
3e 15 - 13 - 12 25 25 
3f 18 19 17 16 16 26 24 
3g 19 21 22 19 19 24 23 
Tetracycline 30 29 27 30 28 - - 
Fluconazole - - - - - 31 30 
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moderately active. Compound 3a, 3b and 3g exhibited most significant activity against S.aureus and 
compound 3a, 3b and 3d towards Pseudomonas. All the other compounds exhibited low to moderate 
activity. (Table-2). The results of antifungal activities are also tabulated in Table-2. Almost all 
compounds are most effectively active against Thrichoderma harzianum and actively inhibited 














































































Acetone 24 h, r.t.
+
2-hydrazino benzothiazoles 2(a-g)








(3a) IR (KBr, cm
-1
) : υ 3491 (N-H stretch), 3063 (Ar-H stretch), 1730 (C=O), 1643 (C=N), 1514 (N-H 
bend), 1452 (Ar C=C), 1315 (C-N), 1271 (C-O), 1095-937 (characteristic of maltose), 709 (C-S); 
1
H 
NMR (CDCl3, ppm): δ 8.123-7.262 (39H, m, Ar-H),  6.248-4.108 (14H, m, maltosyl protons), 5.897-
5.673 (3H, m, NH); Mass (m/z): 1213, 1112, 1110, 1109 (100%), 1019, 1005, 943, 915. (Found : C, 
65.52; H, 4.38; N, 4.35; S, 2.56%; Calcd. for C69H56O18N4S  : C, 65.71; H, 4.44; N, 4.44; S, 2.53 % ).  
 
(3d) IR (KBr, cm
-1
) : υ 3449 (N-H stretch), 3063 (Ar-H stretch), 1730 (C=O), 1601 (C=N), 1584 (N-H 
bend), 1451 (Ar C=C), 1315 (C-N), 1269 (C-O), 1095-937 (characteristic of maltose),  708 (C-S), 687 (C-
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Cl); 
1
H NMR (CDCl3, ppm): δ 8.121-7.370 (38H, m, Ar-H), 6.945-4.228 (14H, m, maltosyl protons), 
5.960-5.657 (3H, m, NH); Mass (m/z): 1213, 1110, 1109 (100%), 1019, 1005, 943, 915, 579. (Found : C, 
63.09; H, 4.21; N, 4.17; S, 2.58%; Calcd. for C69H55O18N4SCl  : C, 63.98; H, 4.25, N, 4.32; S, 2.47 % ). 
(3e) IR (KBr, cm-1) : υ 3460 (N-H stretch), 3063 (Ar-H stretch), 1730 (C=O), 1601 (C=N), 1584 (N-H 
bend), 1450 (Ar C=C), 1315 (C-N), 1269 (C-O), 1093-937 (characteristic of maltose),  709 (C-S); 
1
H 
NMR (CDCl3, ppm): δ 8.124-7.217 (38H, m, Ar-H), 6.213-4.156 (14H, m, maltosyl protons), 5.895-5.672 
(3H, m, NH), 1.601 (3H, s, CH3 protons); Mass (m/z): 1112, 1110, 1109 (100%), 1019, 1005, 943, 915, 
881. (Found : C, 64.83; H, 4.39; N, 4.25; S, 2.08 % Calcd. for C70H58O18N4S : C, 65.93; H, 4.55; N, 4.39; 
S, 2.51% ). 
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